A preliminary look at data from hospitalized adults diagnosed with #COVID19 in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results. https://t.co/QBIw99oZtr pic.twitter.com/7BeqCV0oDO

— Insights @ VUMC (@VUMC_Insights) April 29, 2020